Preoperative radio-chemotherapy in early breast cancer patients: Long-term results of a phase II trial

Radiotherapy and Oncology

Volumn 102, Issue 1, 2012, Pages 82-88

  Bollet, Marc A ^a   Belin, Lisa ^a   Reyal, Fabien ^a   Campana, Franois ^a   Dendale, Rémi ^a   Kirova, Youlia M ^a   Thibault, Fabienne ^a   Diéras, Véronique ^a   Sigal Zafrani, Brigitte ^a   Fourquet, Alain ^a  

^a INSTITUT CURIE   (France)

Author keywords

Breast cancer; Concomitant radio chemotherapy; Preoperative

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; NAVELBINE;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; CONTINUOUS INFUSION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT RESPONSE;

ADULT; AGED; BREAST NEOPLASMS; CHEMORADIOTHERAPY; CYCLOPHOSPHAMIDE; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PREOPERATIVE CARE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME; VINBLASTINE;

EID: 84455191840     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.08.017     Document Type: Article

References (52)

1. M. Clarke, R. Collins, and S. Darby Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2005 2087 2106
2. Early Breast Cancer Trialists Cooperative Group (EBCTCG) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-17.
3. D. Mauri, N. Pavlidis, and J.P. Ioannidis Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis J Natl Cancer Inst 97 2005 188 194
4. V.F. Semiglazov, E.E. Topuzov, and J.L. Bavli Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer Ann Oncol 5 1994 591 595
5. A. Fourquet, J.R. Vilcoq, B. Zafrani, P. Schlienger, D. Jullien, and F. Campana Medullary breast carcinoma: the role of radiotherapy as primary treatment Radiother Oncol 10 1987 1 6
6. L.R. Prosnitz, and I.S. Goldenberg Radiation therapy as primary treatment for early stage carcinoma of the breast Cancer 35 1975 1587 1596
7. R. Calle, J.P. Pilleron, P. Schlienger, and J.R. Vilcoq Conservative management of operable breast cancer: ten years experience at the Foundation Curie Cancer 42 1978 2045 2053
8. M.P. Nobler, and L. Venet Twelve years' experience with irradiation as the primary treatment for breast cancer Int J Radiat Oncol Biol Phys 7 1981 33 42
9. S.M. Scholl, A. Fourquet, and B. Asselain Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6 Eur J Cancer 30A 1994 645 652
10. E. Calitchi, Y. Otmezguine, and F. Feuilhade External irradiation prior to conservative surgery for breast cancer treatment Int J Radiat Oncol Biol Phys 21 1991 325 329
11. E. Huang, M.D. McNeese, and E.A. Strom Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer Int J Radiat Oncol Biol Phys 53 2002 1225 1233
12. P. Broet, S.M. Scholl, and A. de la Rochefordiere Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial Breast Cancer Res Treat 58 1999 151 156
13. J.A. Langendijk, C.R. Leemans, J. Buter, J. Berkhof, and B.J. Slotman The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature J Clin Oncol 22 2004 4604 4612
14. J.A. Green, J.M. Kirwan, and J.F. Tierney Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis Lancet 358 2001 781 786
15. J.S. Cooper, M.D. Guo, and A. Herskovic Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group JAMA 281 1999 1623 1627
16. A. Toledano, D. Azria, and P. Garaud Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial J Clin Oncol 25 2007 405 410
17. J. Rouesse, B. de la Lande, and F. Bertheault-Cvitkovic A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results Int J Radiat Oncol Biol Phys 64 2006 1072 1080
18. G. Arcangeli, P. Pinnaro, R. Rambone, D. Giannarelli, and M. Benassi A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer Int J Radiat Oncol Biol Phys 64 2006 161 167
19. S.C. Formenti, M. Volm, and K.A. Skinner Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial J Clin Oncol 21 2003 864 870
20. S.C. Formenti, G. Dunnington, and B. Uzieli Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-fluorouracil and radiation therapy Int J Radiat Oncol Biol Phys 39 1997 1059 1068
21. S.C. Formenti, W.F. Symmans, and M. Volm Concurrent paclitaxel and radiation therapy for breast cancer Semin Radiat Oncol 9 1999 34 42
22. J. Bonneterre, H. Roche, and A. Monnier Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure Br J Cancer 87 2002 1210 1215
23. A. Zambelli, F.S. Robustelli della Cuna, L. Ponchio, G. Ucci, G.A. Da Prada, and G. Robustelli della Cuna Four-day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer Breast Cancer Res Treat 61 2000 241 247
24. V. Dieras, J.M. Extra, and E. Bellissant Efficacy and tolerance of vinorelbine and fluorouracil combination as first-line chemotherapy of advanced breast cancer: results of a phase II study using a sequential group method J Clin Oncol 14 1996 3097 3104
25. M. Zambetti, R. Demicheli, and D. De Candis Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients Breast Cancer Res Treat 44 1997 255 260
26. K. Fukuoka, H. Arioka, and Y. Iwamoto Mechanism of the radiosensitization induced by vinorelbine in human non-small cell lung cancer cells Lung Cancer 34 2001 451 460
27. M.P. Edelstein, L.A. Wolfe 3rd, and D.S. Duch Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer Semin Oncol 23 1996 41 47
28. G.A. Masters, D.J. Haraf, and P.C. Hoffman Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies J Clin Oncol 16 1998 2157 2163
29. M.A. Bollet, B. Sigal-Zafrani, and L. Gambotti Pathological response to preoperative concurrent chemo-radiotherapy for breast cancer: results of a phase II study Eur J Cancer 42 2006 2286 2295
30. M.A. Bollet, F. Thibault, and K. Bouillon Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study Int J Radiat Oncol Biol Phys 69 2007 13 18
31. D.L. Longo, P.L. Duffey, V.T. DeVita Jr., M.N. Wesley, S.M. Hubbard, and R.C. Young The calculation of actual or received dose intensity: a comparison of published methods J Clin Oncol 9 1991 2042 2051
32. ICRU. Report 50: prescribing, recording, and reporting photon beam therapy. Washington, DC: International Commission on Radiation Units and Measurements; 1993.
33. D.M. Sataloff, B.A. Mason, A.J. Prestipino, U.L. Seinige, C.P. Lieber, and Z. Baloch Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome J Am Coll Surg 180 1995 297 306
34. A. Vincent-Salomon, A. Rousseau, and M. Jouve Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy Eur J Cancer 40 2004 1502 1508
35. A. Vincent-Salomon, M. Carton, and P. Freneaux ERBB2 overexpression in breast carcinomas: no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy Eur J Cancer 36 2000 586 591
36. National Cancer Institute. Common Toxicity Criteria (CTC) v2.0. 1999.
37. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v3.0. 2006.
38. F. Fehlauer, S. Tribius, and U. Holler Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring system Int J Radiat Oncol Biol Phys 55 2003 651 658
39. J.R. Harris, M.B. Levene, G. Svensson, and S. Hellman Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast Int J Radiat Oncol Biol Phys 5 1979 257 261
40. N.K. Aaronson, S. Ahmedzai, and B. Bergman The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
41. D.R. Cox The analysis of multivariate binary data J Roy Stat Soc C (Applied Statistics) 21 1972 113 120
42. A. Vincent-Salomon, G. MacGrogan, and J. Couturier Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS study Histopathology 42 2003 337 347
43. H.D. Bear, S. Anderson, and A. Brown The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27 J Clin Oncol 21 2003 4165 4174
44. J.A. van der Hage, C.J. van de Velde, J.P. Julien, M. Tubiana-Hulin, C. van der velden, and L. Duchateau Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902 J Clin Oncol 19 2001 4224 4237
45. B. Fisher, J. Bryant, and N. Wolmark Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol 16 1998 2672 2685
46. L. Mauriac, M. Durand, A. Avril, and J.M. Dilhuydy Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre Ann Oncol 2 1991 347 354
47. I.E. Smith, R.P. A'Hern, and G.A. Coombes A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial Ann Oncol 15 2004 751 758
48. A.D. Fitoussi, M.G. Berry, and F. Fama Oncoplastic breast surgery for cancer: analysis of 540 consecutive cases [outcomes article] Plast Reconstr Surg 125 2010 454 462
49. M. Colleoni, F. Nole, and I. Minchella Pre-operative chemotherapy and radiotherapy in breast cancer Eur J Cancer 34 1998 641 645
50. B. Aryus, W. Audretsch, and F. Gogolin Remission rates following preoperative chemotherapy and radiation therapy in patients with breast cancer Strahlenther Onkol 176 2000 411 415
51. E.J. Bantema-Joppe, H.P. van der Laan, and G.H. de Bock Three-dimensional conformal hypofractionated simultaneous integrated boost in breast conserving therapy: results on local control and survival Radiother Oncol 100 2011 215 220
52. The FAST Trialists group. First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015). Radiother Oncol 2011;100:93-100.